Detalhe da pesquisa
1.
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.
Cancer Immunol Immunother
; 72(5): 1261-1272, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427086
2.
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies.
Chin J Cancer Res
; 35(3): 245-251, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440831
3.
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma.
Cancer Cell Int
; 21(1): 490, 2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526012
4.
CD8+GITR+ T cells may negatively regulate T cell overactivation in aplastic anemia.
Immunol Invest
; 50(4): 406-415, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462957
5.
T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
Asia Pac J Clin Oncol
; 20(1): 81-86, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635422
6.
A20 Promoter rs5029924 Concomitant with rs2230926 and rs5029937 May Be a Prognostic Predictor for Joint Deformity or Refractory Rheumatoid Arthritis.
Int J Gen Med
; 17: 1707-1712, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706751
7.
Increased co-expression of ICOS and PD-1 predicts poor overall survival in patients with acute myeloid leukemia.
Immunobiology
; 229(3): 152804, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615511
8.
Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort Study.
Infect Dis Ther
; 13(2): 345-359, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265628
9.
High Co-Expression of PDCD1/TIGIT/CD47/KIR3DL2 in Bone Marrow Is Associated with Poor Prognosis for Patients with Myelodysplastic Syndrome.
J Oncol
; 2023: 1972127, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816361
10.
TNFAIP3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.
Cancer Med
; 12(4): 3952-3961, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056685
11.
Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer.
Biomark Res
; 11(1): 26, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879350
12.
Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia.
Ann Med
; 55(1): 2201507, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070487
13.
CASP1 is a target for combination therapy in pancreatic cancer.
Eur J Pharmacol
; 961: 176175, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949157
14.
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.
Cancer Med
; 12(7): 9055-9067, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708053
15.
Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell Lymphoma Patients.
Adv Biol (Weinh)
; 7(12): e2300042, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658484
16.
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis.
Blood Sci
; 4(3): 152-154, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518588
17.
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma.
Biomark Res
; 10(1): 46, 2022 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35831833
18.
Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.
J Oncol
; 2022: 2787426, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35983088
19.
Physalin B inhibits cell proliferation and induces apoptosis in undifferentiated human gastric cancer HGC-27 cells.
Asia Pac J Clin Oncol
; 18(3): 224-231, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161670
20.
Predictive value of TCR Vß-Jß profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial.
JCI Insight
; 7(1)2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014626